Alteration of cytokines and chemokines during febrile episodes associated with endothelial cell damage and plasma leakage in dengue hemorrhagic fever

Pediatric Infectious Disease Journal

Volumn 31, Issue 12, 2012, Pages

  Butthep, Punnee ^a   Chunhakan, Sirichan ^a   Yoksan, Sutee ^a   Tangnararatchakit, Kanchana ^a   Chuansumrit, Ampaiwan ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chemokines; Cytokines; Dengue hemorrhagic fever; Dengue shock syndrome; Endothelial cells damage; Plasma leakage

Indexed keywords

EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ABDOMINAL PAIN; ARTICLE; BLOOD SAMPLING; CHEMOLUMINESCENCE; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DENGUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; ECCHYMOSIS; ENDOTHELIUM CELL; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; OLIGURIA; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESTLESSNESS; SOMNOLENCE; VOMITING;

CYTOKINES; DENGUE HEMORRHAGIC FEVER; ENDOTHELIAL CELLS; FEVER; FLOW CYTOMETRY; HUMANS; IMMUNOASSAY; LUMINESCENT MEASUREMENTS; PLASMA;

EID: 84870863511     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31826fd456     Document Type: Article

References (30)

1. World Health Organization. Dengue: Guideline for Diagnosis, Treatment, Prevention and Control. New edition. Geneva, Switzerland: World Health Organization; 2009.
2. World Health Organization. Dengue and dengue hemorrhagic fever. Factsheet No 117, revised May 2008. Geneva, Switzerland: World Health Organization; 2008.
3. World Health Organization. Dengue Hemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd ed. Geneva, Switzerland: World Health Organization; 1997.
4. Peyrefitte CN, Pastorino B, Grau GE, et al. Dengue virus infection of human microvascular endothelial cells from different vascular beds promotes both common and specific functional changes. J Med Virol. 2006;78: 229-242.
5. Lin C F, Chiu SC, Hsiao YL, et al. Expression of cytokine, chemokine, and adhesion molecules during endothelial cell activation induced by antibodies against dengue virus nonstructural protein 1. J Immunol. 2005;174:395-403.
6. Diamond MS, Edgil D, Roberts TG, et al. Infection of human cells by dengue virus is modulated by different cell types and viral strains. J Virol. 2000;74:7814-7823.
7. Chuansumrit A, Tangnararatchakit K. Dengue hemorrhagic fever; In: Okpala I, Johnson C, eds. Synopsis of Hematology. Charleston, SC: Create Space; 2010: 219-235.
8. Suharti C, van Gorp EC, Setiati TE, et al. The role of cytokines in activation of coagulation and fibrinolysis in dengue shock syndrome. Thromb Haemost. 2002;87:42-46.
9. Rothmam AL. Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms. Nat Rev Immunol. 2011;11:532-543.
10. Anderson R, Wang S, Osiowy C, et al. Activation of endothelial cells via antibody-enhanced dengue virus infection of peripheral blood monocytes. J Virol. 1997;71:4226-4232.
11. Avirutnan P, Malasit P, Seliger B, et al. Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol. 1998;161:6338-6346.
12. Chen YC, Wang S Y. Activation of terminally differentiated human monocytes/macrophages by dengue virus: productive infection, hierarchical production of innate cytokines and chemokines, and the synergistic effect of lipopolysaccharide. J Virol. 2002;76:9877-9887.
13. O'Hayre M, Salanga CL, Handel TM, et al. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J. 2008;409:635-649.
14. Azeredo EL, Zagne SM, Santiago MA, et al. Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever. Immunobiolog y. 2001;204:494-507.
15. Green S, Vaughn DW, Kalayanarooj S, et al. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol. 1999;59:329-334.
16. Kishimoto T, Akira S, Taga T. Interleukin-6 and its receptor: a paradigm for cytokines. Science. 1992;258:593-597.
17. Maruo N, Morita I, Shirao M, et al. IL-6 increases endothelial permeability in vitro. Endocrinology. 1992;131:710-714.
18. Bosch I, Xhaja K, Estevez L, et al. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol. 2002;76:5588-5597.
19. Raghupathy R, Chaturvedi UC, Al-Sayer H, et al. Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol. 1998;56:280-285.
20. Medin CL, Fitzgerald KA, Rothman AL. Dengue virus nonstructural protein NS5 induces interleukin-8 transcription and secretion. J Virol. 2005;79:11053-11061.
21. Halstead SB. Dengue. Curr Opin Infect Dis. 2002;15:471-476.
22. Crone C. Modulation of solute permeability in microvascular endothelium. Fed Proc. 1986;45:77-83.
23. Dewi BE, Takasaki T, Kurane I. In vitro assessment of human endothelial cell permeability: effects of inflammatory cytokines and dengue virus infection. J Virol Methods. 2004;121:171-180.
24. Gunther VJ, Putnak R, Eckels KH, et al. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine. 2011;29:3895-3904.
25. Srikiatkhachorn A, Ajariyakhajorn C, Endy T P, et al. Virus-induced decline in soluble vascular endothelial growth receptor 2 is associated with plasma leakage in dengue hemorrhagic Fever. J Virol. 2007;81:1592-1600.
26. Tseng CS, Lo H W, Teng HC, et al. Elevated levels of plasma VEGF in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol. 2005;43:99-102.
27. Sathupan P, Khongphattanayothin A, Srisai J, et al. The role of vascular endothelial growth factor leading to vascular leakage in children with dengue virus infection. Ann Trop Paediatr. 2007;27:179-184.
28. Seet RC, Chow AW, Quek AM, et al. Relationship between circulating vascular endothelial growth factor and its soluble receptors in adults with dengue virus infection: a case-control study. Int J Infect Dis. 2009;13:e248- e253.
29. Butthep P, Chunhakan S, Tangnararatchakit K, et al. Elevated soluble thrombomodulin in the febrile stage related to patients at risk for dengue shock syndrome. Pediatr Infect Dis J. 2006;25:894-897.
30. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor. Science. 1986;232:1250-1253.